Holly Chan

Holly Chan has over 10 years of professional experience in the pharmaceutical industry. In 2010, they began their career as a Research and Development Intern at Solutia Inc (Eastman Chemical). In 2011, they became a Staff Engineer at Simpson Gumpertz & Heger Inc. and in 2012, they began their graduate studies at Purdue University. From 2015 to 2021, they held various roles at Acorda Therapeutics, Inc., including Manager- Research & CMC, Lead Research Engineer, Senior Research Engineer, and Research Engineer. Most recently, in 2022, they became a Senior Manager, Manufacturing & CMC at Myeloid Therapeutics.

Holly Chan obtained their Bachelor of Science (B.S.) in Chemical Engineering from the University of Massachusetts Amherst in 2011. Holly then continued their studies and earned their Master's Degree in Chemical Engineering from Purdue University in 2014. In 2018, they completed a Certificate in Data Science from the Harvard Extension School. Prior to this, Chan attended the Boston Latin School from 2003 to 2007. Additionally, they hold certifications in Basic Scuba and Engineer in Training (EIT).